Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 2.59 trillion as of December 5, 2025. Its market cap has increased by 13.84% in one year.

Market Cap

2.59T

Enterprise Value

2.58T

Revenue

154.05B

Ranking

n/a

PE Ratio

1,123.15

Stock Price

51,100.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 2.59T, an increase of 9,766.61%. That is a compound annual growth rate of 16.37%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	2,594.85B	32.39%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	1,919.22B	3.31%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	75.96T
Celltrion	40.11T
ALTEOGEN	24.41T
ABL Bio	10.51T
SK Biopharmaceuticals	10.49T
Yuhan	8,755.13B
LigaChem Biosciences	6,753.15B
Peptron	6,645.44B

Market Cap Rankings